Armonica Technologies
Jeremy’s research has focused on interfacing biology, bioinformatics, and engineering. He was the first person to take genome sequence information and develop predictive mathematical models of bacterial metabolism, which started a significant global effort culminating in multiple papers with about 1,000 citations. Stemming from an early interest in genomics technology, Jeremy chose to later work with Dr. George Church at Harvard Medical School in Boston for his post-doctoral studies. This work eventually developed into today’s NGS sequencing technology. Jeremy earned a B.S. in Mechanical Engineering from the University of Texas, Arlington, and a Ph.D. in Bioengineering from The Univerity of California, San Diego.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Armonica Technologies
Armonica Technologies is an early stage medtech company focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications. Armonica’s technology uses proprietary nanochannels to deliver single DNA molecules through nanopores for optical readout by Raman spectroscopy. Armonica’s approach will lead to faster, more thorough, and more accurate genomic analysis than is currently available, without the need for library preparation.